Tag: masitinib
AB Science: possible review for masitinib in ALS
(CercleFinance.com) – AB Science announces that Health Canada has deemed the request for review of masitinib in amyotrophic lateral sclerosis (ALS) admissible. This re-examination process will re-analyze, with new evaluators,…
AB Science falls after Ema requests written details on masitinib – 01/29/2024 at 09:47
(Photo credits: Pixabay – fernando zhiminaicela) (AOF) – AB Science (-11.95% to 3.39 euros) posts one of the biggest drops in the SRD market after announcing that the Committee for…
AB Science: medical use patent for masitinib
(CercleFinance.com) – AB Science announces that the European Patent Office has issued a notice of acceptance for a patent relating to methods (i.e. a patent for medical use) for the…
AB Science: medical use patent for masitinib – 01/15/2024 at 6:36 p.m.
(CercleFinance.com) – AB Science announces that the European Patent Office has issued a notice of acceptance for a patent relating to methods (i.e. a patent for medical use) for the…
AB Science: FDA approval for the Phase 3 study of masitinib in multiple sclerosis
By Olivier Cheilan Published on 29/12/2022 at 6:20 p.m. (Boursier.com) —…
AB Science: ODS designation for masitinib in Switzerland – 12/28/2022 at 08:45
(CercleFinance.com) – AB Science announces that its masitinib has received orphan drug designation (ODS) from the Swiss Institute for Therapeutic Products (Swissmedic) for the treatment of patients with amyotrophic lateral…
AB Science: masitinib received orphan drug designation in Switzerland – 28/12/2022 at 09:33
(AOF) – AB Science SA announces that masitinib has received orphan drug designation (ODS) from the Swiss Institute for Therapeutic Products (Swissmedic) for the treatment of patients with amyotrophic lateral…
AB Science: Masitinib Receives Orphan Drug Designation for the Treatment of ALS in Switzerland
By Alexandra Saintpierre Published on 27/12/2022 at 7:59 p.m. Photo credit © AB Science …
AB Science: green light from the FDA for a confirmatory phase 3 study with masitinib in Alzheimer’s disease
By Olivier Cheilan Posted on 11/21/2022 at 6:29 p.m. (Boursier.com) —…
AB Science: green lights for a study with masitinib in the treatment of Alzheimer’s – 10/10/2022 at 18:28
(AOF) – AB Science has received from the French Medicines Agency (ANSM) as well as from AEMPS (Spanish agency) and EOF (Greek agency), the first regulatory authorizations to initiate its…
AB Science: publication of a positive study for masitinib in the treatment of asthma
By Olivier Cheilan Published on 06/07/2022 at 6:01 p.m. Photo credit © Reuters …
AB Science: important meeting on masitinib
By Alexandra Saintpierre Published on 02/24/2022 at 22:02 Photo credit © AB Science …